Published • loading... • Updated
UK government faces major dilemma over life sciences R&D investment - Optimum Strategic Communications
Summary by Optimum Strategic Communications
1 Articles
1 Articles
UK government faces major dilemma over life sciences R&D investment - Optimum Strategic Communications
If AstraZeneca’s ditching of its plans last January for a long-expected £450 million investment in a vaccine manufacturing in Liverpool was a bright red warning sign, then Merck’s decision this week to can a half-built £1bn research centre in London is a car crash. Pharma executives have been warning the UK’s government ever since it […] The post UK government faces major dilemma over life sciences R&D investment appeared first on Optimum Strat…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium